Novartis reports that Fabhalta® achieved the Phase III APPLAUSE-IgAN primary endpoint, showing slowed kidney-function decline ...
The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...
A type 2 diabetes medication may lower the risk of autoimmune rheumatic diseases like rheumatoid arthritis by 11%, unlike ...
For patients with diabetes and early-stage pulmonary malignancies, administration of a sodium-glucose cotransporter 2 ...
Real-world data reinforce SGLT2 inhibitors as first-line therapy for frail, older adults with heart failure with preserved ...
CHEST 2025, the 90th annual meeting of the American College of Chest Physicians, opens on "Love Your Lungs Day" on October 19 in Chicago.
SGLT2 inhibitors may worsen heart failure outcomes from chemotherapy, highlighting the need for further long-term studies on ...
Researchers have identified that glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are widely used to control type ...
Amazon S3 on MSN
Does Ozempic Raise The Risk Of Mental Health Problems?..
Ozempic, a GLP-1 receptor drug originally for diabetes, has become a major player in the weight loss industry—raising ...
In a study from Korea, adults with type 2 diabetes had a lower risk for autoimmune rheumatic diseases after starting an SGLT2 ...
Emerging clinical evidence supporting an immunomodulatory effect The use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in clinical practice has increased as the multisystem benefits of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback